Global Hematopoietic Stem Cells Transplantation 麻豆原创 Research Report 2024

Publication ID:

PB502243480

Publication Date:

February 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
The global Hematopoietic Stem Cells Transplantation market was valued at US$ 2417.2 million in 2023 and is anticipated to reach US$ 3579.5 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
麻豆原创 competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.
This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells Transplantation.
Report Scope
The Hematopoietic Stem Cells Transplantation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematopoietic Stem Cells Transplantation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematopoietic Stem Cells Transplantation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Segment by Type
Stem Cells Storage
Stem Cells Consumables
Segment by Application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematopoietic Stem Cells Transplantation companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Hematopoietic Stem Cells Transplantation 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cells Storage
1.2.3 Stem Cells Consumables
1.3 麻豆原创 by Application
1.3.1 Global Hematopoietic Stem Cells Transplantation 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Leukemia
1.3.3 Lymphoproliferative Disorders
1.3.4 Solid Tumors
1.3.5 Non-Malignant Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hematopoietic Stem Cells Transplantation 麻豆原创 Perspective (2019-2030)
2.2 Hematopoietic Stem Cells Transplantation Growth Trends by Region
2.2.1 Global Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hematopoietic Stem Cells Transplantation Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Hematopoietic Stem Cells Transplantation Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Hematopoietic Stem Cells Transplantation 麻豆原创 Dynamics
2.3.1 Hematopoietic Stem Cells Transplantation Industry Trends
2.3.2 Hematopoietic Stem Cells Transplantation 麻豆原创 Drivers
2.3.3 Hematopoietic Stem Cells Transplantation 麻豆原创 Challenges
2.3.4 Hematopoietic Stem Cells Transplantation 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hematopoietic Stem Cells Transplantation Players by Revenue
3.1.1 Global Top Hematopoietic Stem Cells Transplantation Players by Revenue (2019-2024)
3.1.2 Global Hematopoietic Stem Cells Transplantation Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Hematopoietic Stem Cells Transplantation 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hematopoietic Stem Cells Transplantation Revenue
3.4 Global Hematopoietic Stem Cells Transplantation 麻豆原创 Concentration Ratio
3.4.1 Global Hematopoietic Stem Cells Transplantation 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematopoietic Stem Cells Transplantation Revenue in 2023
3.5 Hematopoietic Stem Cells Transplantation Key Players Head office and Area Served
3.6 Key Players Hematopoietic Stem Cells Transplantation Product Solution and Service
3.7 Date of Enter into Hematopoietic Stem Cells Transplantation 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematopoietic Stem Cells Transplantation Breakdown Data by Type
4.1 Global Hematopoietic Stem Cells Transplantation Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Hematopoietic Stem Cells Transplantation Forecasted 麻豆原创 Size by Type (2025-2030)
5 Hematopoietic Stem Cells Transplantation Breakdown Data by Application
5.1 Global Hematopoietic Stem Cells Transplantation Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Hematopoietic Stem Cells Transplantation Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Hematopoietic Stem Cells Transplantation 麻豆原创 Size (2019-2030)
6.2 North America Hematopoietic Stem Cells Transplantation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Country (2019-2024)
6.4 North America Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hematopoietic Stem Cells Transplantation 麻豆原创 Size (2019-2030)
7.2 Europe Hematopoietic Stem Cells Transplantation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Country (2019-2024)
7.4 Europe Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hematopoietic Stem Cells Transplantation 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Hematopoietic Stem Cells Transplantation 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hematopoietic Stem Cells Transplantation 麻豆原创 Size (2019-2030)
9.2 Latin America Hematopoietic Stem Cells Transplantation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hematopoietic Stem Cells Transplantation 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Hematopoietic Stem Cells Transplantation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Hematopoietic Stem Cells Transplantation 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CBR Systems
11.1.1 CBR Systems Company Detail
11.1.2 CBR Systems Business Overview
11.1.3 CBR Systems Hematopoietic Stem Cells Transplantation Introduction
11.1.4 CBR Systems Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.1.5 CBR Systems Recent Development
11.2 China Cord Blood Corporation
11.2.1 China Cord Blood Corporation Company Detail
11.2.2 China Cord Blood Corporation Business Overview
11.2.3 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Introduction
11.2.4 China Cord Blood Corporation Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.2.5 China Cord Blood Corporation Recent Development
11.3 ViaCord
11.3.1 ViaCord Company Detail
11.3.2 ViaCord Business Overview
11.3.3 ViaCord Hematopoietic Stem Cells Transplantation Introduction
11.3.4 ViaCord Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.3.5 ViaCord Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Introduction
11.4.4 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 STEMCELL Technologies
11.5.1 STEMCELL Technologies Company Detail
11.5.2 STEMCELL Technologies Business Overview
11.5.3 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Introduction
11.5.4 STEMCELL Technologies Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.5.5 STEMCELL Technologies Recent Development
11.6 Vcanbio
11.6.1 Vcanbio Company Detail
11.6.2 Vcanbio Business Overview
11.6.3 Vcanbio Hematopoietic Stem Cells Transplantation Introduction
11.6.4 Vcanbio Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.6.5 Vcanbio Recent Development
11.7 Merck Millipore
11.7.1 Merck Millipore Company Detail
11.7.2 Merck Millipore Business Overview
11.7.3 Merck Millipore Hematopoietic Stem Cells Transplantation Introduction
11.7.4 Merck Millipore Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.7.5 Merck Millipore Recent Development
11.8 Lonza Group
11.8.1 Lonza Group Company Detail
11.8.2 Lonza Group Business Overview
11.8.3 Lonza Group Hematopoietic Stem Cells Transplantation Introduction
11.8.4 Lonza Group Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.8.5 Lonza Group Recent Development
11.9 CellGenix Technologie Transfer
11.9.1 CellGenix Technologie Transfer Company Detail
11.9.2 CellGenix Technologie Transfer Business Overview
11.9.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Introduction
11.9.4 CellGenix Technologie Transfer Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.9.5 CellGenix Technologie Transfer Recent Development
11.10 ThermoGenesis
11.10.1 ThermoGenesis Company Detail
11.10.2 ThermoGenesis Business Overview
11.10.3 ThermoGenesis Hematopoietic Stem Cells Transplantation Introduction
11.10.4 ThermoGenesis Revenue in Hematopoietic Stem Cells Transplantation Business (2019-2024)
11.10.5 ThermoGenesis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.